Current capabilities of targeted biological therapy for severe bronchial asthma and prospects for personalized selection
Pharmateca · 09.10.2026 · 6_2026 · 8-16
DOI: 10.18565/pharmateca.2026.6.8-16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmateca, erschienen am 09.10.2026. Verfasst von Starodubtseva I.A. Starodubtseva und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Starodubtseva, S. I., Lesina, L. V., Cherenkova, C. O., Mubarakshina, M. O., & Sharapova, S. Y. (2026). Current capabilities of targeted biological therapy for severe bronchial asthma and prospects for personalized selection. Pharmateca, 6_2026, 8-16. https://doi.org/10.18565/pharmateca.2026.6.8-16
Vancouver
Starodubtseva SI, Lesina LV, Cherenkova CO, Mubarakshina MO, Sharapova SY. Current capabilities of targeted biological therapy for severe bronchial asthma and prospects for personalized selection. Pharmateca. 2026;6_2026:8-16. doi:10.18565/pharmateca.2026.6.8-16
BibTeX
@article{Starodubtseva2026,
author = {Starodubtseva, Starodubtseva I.A. and Lesina, Lesina V.S. and Cherenkova, Cherenkova O.V. and Mubarakshina, Mubarakshina O.A. and Sharapova, Sharapova Yu.A.},
title = {Current capabilities of targeted biological therapy for severe bronchial asthma and prospects for personalized selection},
journal = {Pharmateca},
year = {2026},
volume = {6_2026},
pages = {8--16},
doi = {10.18565/pharmateca.2026.6.8-16}
}
EUVIMED